The strongest data we have and why including myself bought into this company unfortunately is only anecdotal evidence the scientific evidence is really in a pragmatic sense good but not strong enough in terms of people treated.
PR is talking deals for MPS based on a handful of patients seems far fetched hence at the moment no deals
We have a weak board that lets the founder call all the shots even dismissing the CEO who was not there long enough to have his name printed on the payroll for basically no apparent reason even though he employed him and he came well credentialed.
The market obviously doesn't believe PRs data as they think its biased a new CEO can't come quick enough
Ann: Successful completion of Retail Entitlement Offer, page-47
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $77.86M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.5¢ | $61.79K | 277.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 112911 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 111856 | 7 |
View Market Depth
| Last trade - 13.09pm 11/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |